Assay method for quality control and stability studies of a new antimalarial agent (CDRI 99/411)

CDRI compound no. 99/411 is a potent 1,2,4-trioxane antimalarial candidate drug under development at our Institute. An HPLC method for determination of CDRI 99/411 with its starting material and intermediates has been developed and validated for in process quality control and stability studies. The...

Full description

Bibliographic Details
Main Authors: Kiran Khandelwal, Shakti Deep Pachauri, Sofia Zaidi, Pankaj Dwivedi, Ashok Kumar Sharma, Chandan Singh, Anil Kumar Dwivedi
Format: Article
Language:English
Published: Elsevier 2013-10-01
Series:Journal of Pharmaceutical Analysis
Online Access:http://www.sciencedirect.com/science/article/pii/S2095177913000397
_version_ 1819294966566879232
author Kiran Khandelwal
Shakti Deep Pachauri
Sofia Zaidi
Pankaj Dwivedi
Ashok Kumar Sharma
Chandan Singh
Anil Kumar Dwivedi
author_facet Kiran Khandelwal
Shakti Deep Pachauri
Sofia Zaidi
Pankaj Dwivedi
Ashok Kumar Sharma
Chandan Singh
Anil Kumar Dwivedi
author_sort Kiran Khandelwal
collection DOAJ
description CDRI compound no. 99/411 is a potent 1,2,4-trioxane antimalarial candidate drug under development at our Institute. An HPLC method for determination of CDRI 99/411 with its starting material and intermediates has been developed and validated for in process quality control and stability studies. The analytical performance parameters such as linearity, precision, accuracy, specificity, limit of detection (LOD) and lower limit of quantification (LLOQ) were determined according to International Conference on Harmonization ICH Q2(R1) guidelines. HPLC separation was achieved on a RP-select B Lichrosphere® column (250 mmÃ4 mm, 5 μm, Merck) using water containing 0.1% glacial acetic acid and acetonitrile as the mobile phase in a gradient elution. The eluents were monitored by a photo diode array detector at 245 and 275 nm. Based on signal to noise ratio of 3 and 10 the LOD of CDRI 99/411 was 0.55 µg/mL, while the LLOQ was 1.05 µg/mL. The calibration curves were linear in the range of 1.05â68 µg/mL. Precision of the method was determined by inter- and intra-assay variations within the acceptable range. Keywords: HPLC, Trioxane, Process quality control, Stability
first_indexed 2024-12-24T04:34:43Z
format Article
id doaj.art-f9122fe64f184697a9c12153aa3f6ec2
institution Directory Open Access Journal
issn 2095-1779
language English
last_indexed 2024-12-24T04:34:43Z
publishDate 2013-10-01
publisher Elsevier
record_format Article
series Journal of Pharmaceutical Analysis
spelling doaj.art-f9122fe64f184697a9c12153aa3f6ec22022-12-21T17:15:16ZengElsevierJournal of Pharmaceutical Analysis2095-17792013-10-0135335340Assay method for quality control and stability studies of a new antimalarial agent (CDRI 99/411)Kiran Khandelwal0Shakti Deep Pachauri1Sofia Zaidi2Pankaj Dwivedi3Ashok Kumar Sharma4Chandan Singh5Anil Kumar Dwivedi6Division of Pharmaceutics, CSIR-Central Drug Research Institute, Chattar Manzil Palace, Lucknow 226001, IndiaDivision of Pharmaceutics, CSIR-Central Drug Research Institute, Chattar Manzil Palace, Lucknow 226001, IndiaDivision of Pharmaceutics, CSIR-Central Drug Research Institute, Chattar Manzil Palace, Lucknow 226001, IndiaDivision of Pharmaceutics, CSIR-Central Drug Research Institute, Chattar Manzil Palace, Lucknow 226001, IndiaDivision of Medicinal and Process Chemistry, CSIR-Central Drug Research Institute, Chattar Manzil Palace, Lucknow 226001, IndiaDivision of Medicinal and Process Chemistry, CSIR-Central Drug Research Institute, Chattar Manzil Palace, Lucknow 226001, IndiaDivision of Pharmaceutics, CSIR-Central Drug Research Institute, Chattar Manzil Palace, Lucknow 226001, India; Corresponding author at: Pharmaceutics Division, CSIR-Central Drug Research Institute, Post Box No.173, MG Road, Lucknow 226001, India.Tel.: +91 522 2623405; fax: +91 522 2623938.CDRI compound no. 99/411 is a potent 1,2,4-trioxane antimalarial candidate drug under development at our Institute. An HPLC method for determination of CDRI 99/411 with its starting material and intermediates has been developed and validated for in process quality control and stability studies. The analytical performance parameters such as linearity, precision, accuracy, specificity, limit of detection (LOD) and lower limit of quantification (LLOQ) were determined according to International Conference on Harmonization ICH Q2(R1) guidelines. HPLC separation was achieved on a RP-select B Lichrosphere® column (250 mmÃ4 mm, 5 μm, Merck) using water containing 0.1% glacial acetic acid and acetonitrile as the mobile phase in a gradient elution. The eluents were monitored by a photo diode array detector at 245 and 275 nm. Based on signal to noise ratio of 3 and 10 the LOD of CDRI 99/411 was 0.55 µg/mL, while the LLOQ was 1.05 µg/mL. The calibration curves were linear in the range of 1.05â68 µg/mL. Precision of the method was determined by inter- and intra-assay variations within the acceptable range. Keywords: HPLC, Trioxane, Process quality control, Stabilityhttp://www.sciencedirect.com/science/article/pii/S2095177913000397
spellingShingle Kiran Khandelwal
Shakti Deep Pachauri
Sofia Zaidi
Pankaj Dwivedi
Ashok Kumar Sharma
Chandan Singh
Anil Kumar Dwivedi
Assay method for quality control and stability studies of a new antimalarial agent (CDRI 99/411)
Journal of Pharmaceutical Analysis
title Assay method for quality control and stability studies of a new antimalarial agent (CDRI 99/411)
title_full Assay method for quality control and stability studies of a new antimalarial agent (CDRI 99/411)
title_fullStr Assay method for quality control and stability studies of a new antimalarial agent (CDRI 99/411)
title_full_unstemmed Assay method for quality control and stability studies of a new antimalarial agent (CDRI 99/411)
title_short Assay method for quality control and stability studies of a new antimalarial agent (CDRI 99/411)
title_sort assay method for quality control and stability studies of a new antimalarial agent cdri 99 411
url http://www.sciencedirect.com/science/article/pii/S2095177913000397
work_keys_str_mv AT kirankhandelwal assaymethodforqualitycontrolandstabilitystudiesofanewantimalarialagentcdri99411
AT shaktideeppachauri assaymethodforqualitycontrolandstabilitystudiesofanewantimalarialagentcdri99411
AT sofiazaidi assaymethodforqualitycontrolandstabilitystudiesofanewantimalarialagentcdri99411
AT pankajdwivedi assaymethodforqualitycontrolandstabilitystudiesofanewantimalarialagentcdri99411
AT ashokkumarsharma assaymethodforqualitycontrolandstabilitystudiesofanewantimalarialagentcdri99411
AT chandansingh assaymethodforqualitycontrolandstabilitystudiesofanewantimalarialagentcdri99411
AT anilkumardwivedi assaymethodforqualitycontrolandstabilitystudiesofanewantimalarialagentcdri99411